Global Assets Advisory’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.56M Buy
7,174
+90
+1% +$20K 0.46% 49
2025
Q4
$1.62M Buy
7,084
+215
+3% +$49K 0.46% 50
2025
Q3
$1.59M Buy
6,869
+612
+10% +$125K 0.47% 52
2025
Q2
$1.19M Sell
6,257
-5,275
-46% -$980K 0.46% 55
2025
Q1
$2.16M Buy
11,532
+6,969
+153% +$1.35M 0.41% 56
2024
Q4
$819K Sell
4,563
-496
-10% -$91.2K 0.45% 56
2024
Q3
$996K Buy
+5,059
New +$944K 0.55% 49
2024
Q2
Sell
-873,418
Closed -$4.83M 65
2024
Q1
$4.83M Buy
+873,418
New +$151M 0.22% 93
2023
Q4
Sell
-6,498
Closed -$969K 56
2023
Q3
$969K Sell
6,498
-2,215
-25% -$325K 0.85% 32
2023
Q2
$1.18M Buy
8,713
+2,214
+34% +$325K 1.08% 27
2023
Q1
$1.04M Buy
6,499
+1,248
+24% +$191K 1.06% 25
2022
Q4
$849K Sell
5,251
-400
-7% -$61.3K 0.89% 29
2022
Q3
$827K Buy
5,651
+1,546
+38% +$222K 0.84% 29
2022
Q2
$629K Buy
+4,105
New +$627K 1.36% 17

Other funds holding ABBV